Overview
Beena Sachan practices practicing medicine in Lucknow, India.
Her clinical expertise encompasses Type A Insulin Resistance Syndrome, Acanthosis Nigricans, and Melasma.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Lucknow, UP, India
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Beena Sachan
Is Beena Sachan a top-rated expert for Type A Insulin Resistance Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Beena Sachan is classified as an Experienced expert for Type A Insulin Resistance Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Beena Sachan participate in research or clinical trials?
Yes. Beena Sachan has published 10 articles and abstracts on conditions like Type A Insulin Resistance Syndrome. You can view a list of Beena Sachan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acanthosis NigricansMs. Sachan isExperienced. Learn about Acanthosis Nigricans.
- MelasmaMs. Sachan isExperienced. Learn about Melasma.
- Type A Insulin Resistance SyndromeMs. Sachan isExperienced. Learn about Type A Insulin Resistance Syndrome.